Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of tolvaptan for hyponatremia in hospitalized medical-surgical patients
2010-024431-17Phase 2Terminated
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of tolvaptan in hyponatraemia (2 arms), sponsored by Mario Negri Institute for Pharmacological Research. Primary endpoints: Proportion achieving normonatremia and Absolute change in serum sodium from baseline. Started Dec 2011; status: terminated.
02
Drugs
tolvaptan
03
Conditions
hyponatraemia
Beyond the preview
Go deeper on 2010-024431-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024431-17.